Ibuprofen in needle procedures in children with cancer-A feasibility and pilot study

Tove Kamsvåg1, Lena Hedén1,2, Louise von Essen3

  • 1Department of Women's and Children's Health, Pediatric Oncology, Uppsala University, Uppsala, Sweden.

Insights

This pilot study explored using oral ibuprofen for children

Area of Science:

  • Pediatric Anesthesiology
  • Pain Management
  • Clinical Trial Feasibility

Background:

  • Needle-insertion procedures in children can cause pain, fear, and distress.
  • Effective pain management strategies are crucial for pediatric patients undergoing medical interventions.
  • Subcutaneously implanted intravenous ports require needle access, necessitating pain mitigation.

Purpose of the Study:

  • To assess the feasibility of a randomized clinical trial on oral ibuprofen for needle-insertion pain in children.
  • To investigate if oral ibuprofen reduces pain, fear, and distress compared to placebo.
  • To establish recruitment and protocol adherence benchmarks for future pediatric pain trials.

Main Methods:

  • A pilot randomized clinical trial involving 23 children.
  • Children were randomized to receive either oral ibuprofen (7.5 mg/kg) or placebo before needle insertion.
  • Pain, fear, and distress were assessed by children (≥7 years), parents, and nurses; s-cortisol levels were also measured.

Main Results:

  • The study did not meet key feasibility criteria, primarily due to low recruitment and consent rates.
  • No trend of benefit was observed for oral ibuprofen regarding pain, fear, or distress compared to placebo.
  • All feasibility criteria were met except for recruitment and patient consent.

Conclusions:

  • The pilot study failed to meet feasibility targets, leading to its closure.
  • While not definitively disproven, the data suggest oral ibuprofen is unlikely to be beneficial for needle-insertion pain in this context.
  • Further research with improved recruitment strategies may be needed to confirm or refute ibuprofen's efficacy.
Abstract